Catalog No. :	CL1027
Product Name :	Miglustat
CAS No. :	72599-27-0
Synonyms :	Miglustat (N-Butyldeoxynojirimycin)
Chemical Name :	(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
Molecular Formula :	C10H21NO4
Molecular Weight :	219.28
Molecular Structure :
Appearance :	White to off-white powder
Specification :	98+%
Application :	Research on Gaucher's disease | Glucosylceramide Synthase
Registration :
Storage Condition :	Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).

Miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) is an orally administered ceramide glucosyltransferase inhibitor which prevents the lysosomal accumulation of glucocerebroside.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.